Cécile Vialet, MSc
- 2Articles
- 9KReads
- 2013–2015Active
- 4Collaborators
- 107Citations
About
Cécile Vialet, MSc, has published research focused on the treatment of major depressive disorder (MDD), specifically investigating the efficacy and safety of desvenlafaxine at a 50 mg/day dosage. Her work includes randomized controlled trials examining both long-term treatment and relapse prevention in MDD. Vialet has collaborated frequently with co-authors such as Eunhee Hwang, Karen A. Tourian, Patrice Boyer, and Joshua Z. Rosenthal.
Publications
Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial
August 27, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
